OpenAI isn’t built for health care. So why is its tech already in hospitals, pharma, and cancer care?
OpenAI isn’t built for health care but it’s already inking deals with health care companies.
Related Articles
China tops the world in artificial intelligence publications, database analysis reveals
The country also leads in patent filings and the number of AI researchers
SRT-H: A hierarchical framework for autonomous surgery via language-conditioned imitation learning
A language-guided imitation learning framework achieves step-level autonomy in robotic cholecystectomy surgeries.
Elegen and Nutcracker Pilot Cell-Free Manufacturing Process for RNA-Based Personalized Cancer Therapeutics
Nutcracker Therapeutics and Elegen see their mission as delivering scalable and low-cost RNA manufacturing for individualized therapies.
Effort to revive New Zealand’s extinct moa stirs controversy
Suggestions that nation’s Indigenous Māori wholeheartedly back project draws criticism
PEPFAR keeps millions of people with HIV alive and may be spared from Trump spending cuts
The HIV/AIDS program known as PEPFAR has faced a severe threat as the Trump administration dismantles most foreign aid, but on Tuesday it appeared to be spared…
Tissue-integrated bionic knee restores versatile legged movement after amputation
Lower-extremity prostheses have evolved through mechanical redesigns that prioritize improved cyclic locomotion. However, this limited approach to limb restoration has precluded necessary progress toward recovering…
An unusual use for AI in medical education
In this edition of AI Prognosis: A look at AI in medical education, CASP getting caught up in NIH chaos, and trust in AI.
AbbVie Licenses IGI Myeloma Candidate ISB 2001 for Up to $1.9B+
AbbVie has acquired global rights to the lead pipeline asset of Ichnos Glenmark Innovation (IGI), the cancer and autoimmune disease candidate ISB 2001, through an…
ViiV expands licensing deal for its HIV drug in low-income countries
ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, reflecting ongoing pressure to respond to criticism.
UK Biobank Completes World’s Largest Whole-Body Imaging Project
After more than a decade of planning and execution, UK Biobank has completed the largest whole-body imaging study in history—scanning the brains, hearts, abdomens, blood…
